Table 2.
Self-Reported (IPAQ) | Device-Measured | ||||
---|---|---|---|---|---|
Median (IQR) | Participants with Zero Value, n (%) | Median (IQR) | Participants with Zero Value, n (%) | ||
Walking (h/week) | All participants | 2.25 (0.17, 7.00) | 8 (20) | 0.00 (0.00, 0.94) | 28 (70) |
UL injury | 3.50 (1.25, 7.00) | 3 (16) | 0.33 (0.00, 4.80) | 9 (47) | |
LL injury | 0.75 (0.17, 4.00) | 5 (24) | 0.00 (0.00, 0.00) | 19 (91) | |
MPA (h/week) | 0.0 (0.0, 0.0) | 37 (82) | 0.0 (0.0, 0.4) | 33 (73) | |
VPA (h/week) | 0.0 (0.0, 0.0) | 40 (89) | 0.0 (0.0, 0.0) | 44 (98) | |
METmins (total/week) | All participants | 550 (140, 1725) | 5 (13) | 0 (0, 487) | 27 (68) |
UL injury | 693 (396, 2376) | 2 (11) | 306 (0, 1542) | 8 (42) | |
LL injury | 264 (66, 924) | 3 (14) | 0 (0, 0) | 19 (91) | |
Sitting (hr/day) | All participants | 8.00 (5.00, 11.00) | 0 | 10.59 (9.81, 12.05) | 0 |
UL injury | 6.00 (4.50, 8.00) | 0 | 10.04 (8.71, 10.53) | 0 | |
LL injury | 10.50 (6.00, 12.50) | 0 | 11.73 (10.68, 12.87) | 0 |
Moderate-intensity Physical Activity (MPA), Vigorous-intensity Physical Activity (VPA), Metabolic Equivalent minutes (METmins), upper limb (UL), lower limb (LL).